SOURCES SOUGHT
D -- Mobile End User Experience Monitoring - FDA RFI 1196100 – Mobile End User Experience Monitoring
- Notice Date
- 3/6/2018
- Notice Type
- Sources Sought
- NAICS
- 541519
— Other Computer Related Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- 1196100
- Archive Date
- 4/5/2018
- Point of Contact
- Jacob A. O'Hatnick, Phone: 2404027545
- E-Mail Address
-
jacob.ohatnick@fda.hhs.gov
(jacob.ohatnick@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- FDA RFI 1196100 – Mobile End User Experience Monitoring Mobile End User Experience Monitoring Request for Information (# 1196100) This RFI is included as an attachment, as well as in full text as follows: Background/Objectives: This RFI seeks to solicit informal input regarding an End User Experience Monitoring solution for the U.S. Food and Drug Administration (FDA). This solution would be used with the current mobile infrastructure to monitor the end user experience for mobile devices in the FDA portfolio. FDA mobile users utilize a variety of iOS and Samsung Android devices and there is a need for a product that monitors user interactions, device health and performance, and application performance. There are plans to expand device offerings to additional Android device types. FDA does not currently have a Bring Your Own Device (BYOD) program; all devices are government furnished equipment (GFE). FDA is requesting that vendors ensure that the responses provided can meet requirements identified in in this RFI. Vendors may also provide alternative approaches and best practices to meet FDA's mobile needs. Basic Requirements: • iOS and Android devices. • Detailed device reporting capabilities (i.e., serial number, model, running version of operating system, etc.) • Real time alerts. About this RFI: This RFI is issued solely for information and planning purposes - it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This request for information does not commit the Government to contract for any supply or service whatsoever. Further, the FDA is not at this time seeking proposals and will not accept unsolicited proposals. Respondees are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party's expense. Not responding to this RFI does not preclude participation in any future RFP, if any is issued. The information provided in the RFI is subject to change and is not binding on the Government. The FDA has not made a commitment to procure any of the items or services discussed, and release of this RFI should not be construed as such a commitment or as authorization to incur cost for which reimbursement would be required or sought. All submissions become Government property and will not be returned. FDA representatives may or may not choose to meet with potential offerors. Such discussions would only be intended to get further clarification of potential capability to meet the requirements, especially any development and certification risks. Submission Instructions: Please email responses to the contact of this RFI: Jacob.ohatnick@fda.hhs.gov Email should have the RFI Title in the subject line. Responses should be pdf or MS Office format. Files with macros,.exe All respondents are asked to indicate the type and size of their organization (e.g. large business, small business, veteran-owned small business, service-disabled veteran-owned small business, HUBZone small business, small disadvantaged business, women-owned business, 8(a), historically black college or university/minority institution, education institution, profit/non-profit hospital, or other nonprofit organizations including those within the federal government). Information Sought The Government is looking for answers to the below technical questions to assist the Government in completing its market research. 1. Product Deployment How will this solution be deployed? Is there an on-premise option, if so please describe? What costs are associated with an on-premise deployment (e.g. does your product require consulting services to install on-premise)? What is the level of difficulty for installation of your solution? What is the availability of vendor services for initial setup? Installation will be conducted at FDA HQ in Silver Spring, MD. 2. Is a Cloud solution available? If so, who is the Cloud Service Provider? Is the Cloud solution FedRAMP authorized? If the Cloud solution is not FedRAMP authorized: o Whose Cloud environment is your solution built on? o Does your Cloud solution leverage data centers that reside outside the continental United States, and if so, where? o What independent third party audits have been conducted against your cloud solution? What is your Cloud's downtime to uptime ratio? Where is Cloud service support model? On the client side, how is the solution deployed to mobile devices? 3. Product Capabilities / Info What makes your product superior or unique as compared to competitors? How can your product be customized? How does your product provide a holistic view of the end user experience? Is your product 508 compliant? Please describe. Is there any user interaction with your product? Please list all Mobile Device Management (MDM) solutions available for integration with your product and describe how your product integrates with each MDM. Does your product integrate with security information and event management (SIEM) solutions (such as Splunk)? If so, please list all SIEMs and describe how the integration is accomplished. What iOS models and OS releases does your product support? Which Android Models and Android OS releases does your product support? Can your product analyze Samsung Android devices? Can your product analyze Samsung specific services (e.g. KNOX)? What support does your product provide for BlackBerry Android devices? Is your product able to analyze Windows 10 devices? Describe how your product monitors user interactions, performance, and application for mobile applications from the end user perspective. Does your product provide the ability to monitor public and Enterprise applications? Please describe all metrics captured by your product for mobile devices and mobile applications. What data is provided in real time alerts? How are real time alerts generated and reported to system administrators? What are your product's authentication options? If applicable, please describe the authentication process for administrators when accessing the administrator console. What options does your product provide for authenticating to the admin console? What is the security of external connections made by the tool, and data reported? Describe how your product protects the privacy of users and user's data. How does your solution impact battery life on a mobile device? Please describe your technical support services. Please describe your system maintenance plan (e.g. software version updates, bug fixes, etc.) • Describe for Cloud • Describe for On-Premise Deployment What external 3rd party audits have been conducted against your product (e.g. ISO 27001)? Please describe. 4. Reporting What reporting capabilities does your product have? What discrete data can be captured and reported? How is that data displayed? What reporting capabilities does your product have on device resource usage? Does your product have the ability to report on cellular and Wi-Fi network response time? Does your product have the ability to capture and report error logging that can be used to make improvements to mobile apps? Please provide a variety of sample reports. 5. Licensing Please describe your licensing models. Are there any maintenance fees? Is your solution available on NASA SEWP, NITAAC CIO-SP3, GSA, or any other Government wide acquisition contracts (GWAC)? If so, please provide the contract number. 6. References Please provide references of other federal Agencies/Departments where your product has been implemented in the production environment. Please provide references of other federal Agencies/Departments where your product has been implemented in a non-production environment Please provide references from private industry where your product has been implemented.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1196100/listing.html)
- Place of Performance
- Address: U.S. Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN04844584-W 20180308/180306231450-c902ad092e3520a1a36e2ebc924c2e8a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |